Isabelle Goy-Thollot

Isabelle Goy-Thollot

Auto-generated profile, based on publicly available information

Isabelle Goy-Thollot

University of Lyon France

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Open access
PDF file
EDElizabeth B. Davidow
Elizabeth B. Davidow
SBShauna L. Blois
Shauna L. Blois
IGIsabelle Goy‐Thollot
Isabelle Goy‐Thollot
LHLauren Harris
Lauren Harris
KHKaren Humm
Karen Humm
KWK. Jane Wardrop
K. Jane Wardrop
Objective: To use a systematic, evidence‐based consensus process to develop definitions for transfusion reactions in dogs and cats.Design: Evidence evaluation of the literature was carried out for identified transfusion reaction types in dogs and cats. Reaction definitions were generated based on synthesis of human and veterinary literature. Consensus on the definitions was achieved through Delphi‐style surveys. Draft recommendations were made available through industry specialty listservs and comments were incorporated.Results: Definitions with imputability criteria were developed for 14 types of transfusion reactions.Conclusions: The evidence review and consensus process resulted in definitions that can be used to facilitate future veterinary transfusion reaction research.

10 March 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Open access
PDF file
EDElizabeth B. Davidow
Elizabeth B. Davidow
SBShauna L. Blois
Shauna L. Blois
IGIsabelle Goy‐Thollot
Isabelle Goy‐Thollot
LHLauren Harris
Lauren Harris
KHKaren Humm
Karen Humm
KWK. Jane Wardrop
K. Jane Wardrop
Objective: To systematically review available evidence to develop guidelines for the prevention of transfusion reactions and monitoring of transfusion administration in dogs and cats.Design: Evidence evaluation of the literature (identified through Medline searches through Pubmed and Google Scholar searches) was carried out for identified transfusion reaction types in dogs and cats. Evidence was evaluated using PICO (Population, Intervention, Comparison, Outcome) questions generated for each reaction type. Evidence was categorized by level of evidence (LOE) and quality (Good, Fair, or Poor). Guidelines for prevention and monitoring were generated based on the synthesis of the evidence. Consensus on the final recommendations and a proposed transfusion administration monitoring form was achieved through Delphi‐style surveys. Draft recommendations and the monitoring form were made available through veterinary specialty listservs and comments were incorporated.Results: Twenty‐nine guidelines and a transfusion administration monitoring form were formulated from the evidence review with a high degree of consensusConclusions: This systematic evidence evaluation process yielded recommended prevention and monitoring guidelines and a proposed transfusion administration form. However, significant knowledge gaps were identified, demonstrating the need for additional research in veterinary transfusion medicine.

1 September 2017 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
IGI. Goy-Thollot
I. Goy-Thollot
UGU. Giger
U. Giger
CBC. Boisvineau
C. Boisvineau
RPR. Perrin
R. Perrin
MGM. Guidetti
M. Guidetti
BCB. Canard
B. Canard
When dogs are transfused, blood compatibility testing varies widely but may include dog erythrocyte antigen (DEA) 1 typing and rarely cross-matching. Prospective study to examine naturally occurring alloantibodies against red blood cells (RBCs) and alloimmunization by transfusion using 2 antiglobulin-enhanced cross-match tests. Eighty client-owned anemic, 72 donor, and 7 control dogs. All dogs were typed for DEA 1 and some also for DEA 4 and DEA 7. Major cross-match tests with canine antiglobulin-enhanced immunochromatographic strip and gel columns were performed 26–129 days post-transfusion (median, 39 days); some dogs had an additional early evaluation 11–22 days post-transfusion (median, 16 days). Plasma from alloimmunized recipients was cross-matched against RBCs from 34 donor and control dogs. The 2 cross-match methods gave entirely concordant results. All 126 pretransfusion cross-match results for the 80 anemic recipients were compatible, but 54 dogs died or were lost to follow up. Among the 26 recipients with follow-up, 1 dog accidently received DEA 1-mismatched blood and became cross-match-incompatible post-transfusion. Eleven of the 25 DEA 1-matched recipients (44%) became incompatible against other RBC antigens. No naturally occurring anti-DEA 7 alloantibodies were detected in DEA 7− dogs. The antiglobulin-enhanced immunochromatographic strip cross-match and laboratory gel column techniques identified no naturally occurring alloantibodies against RBC antigens, but a high degree of post-transfusion alloimmunization in dogs. Cross-matching is warranted in any dog that has been previously transfused independent of initial DEA 1 typing and cross-matching results before the first transfusion event.

10 March 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Open access
PDF file
AOAdesola Odunayo
Adesola Odunayo
KNKatherine J Nash
Katherine J Nash
EDElizabeth B. Davidow
Elizabeth B. Davidow
SBShauna L. Blois
Shauna L. Blois
IGIsabelle Goy‐Thollot
Isabelle Goy‐Thollot
KWK. Jane Wardrop
K. Jane Wardrop
Objective: To systematically review available evidence to develop guidelines for diagnosis and treatment of transfusion‐associated reactions in dogs and cats.Design: Standardized and systemic evaluation of the literature (identified through Medline via PubMed and Google Scholar searches) was carried out for identified transfusion reaction types in dogs and cats. The available evidence was evaluated using PICO (Population, Intervention, Comparison, Outcome) questions generated for each reaction type. The evidence was categorized by level of evidence (LOE) and quality (Good, Fair, or Poor). Guidelines, diagnostic, and treatment algorithms were generated based on the evaluation of the evidence. Consensus on the final guidelines was achieved through Delphi‐style surveys. Draft recommendations were disseminated through veterinary specialty listservs for review and comments, which were evaluated and integrated prior to final publication.Results: Medline via PubMed and Google Scholar databases were searched. There were 14 Population Intervention Comparison Outcome questions identified and corresponding worksheets were developed focusing on the diagnosis and treatment of transfusion‐associated reactions in dogs and cats. Fourteen guidelines and four algorithms were developed with a high degree of consensus.Conclusions: This systematic evidence evaluation process yielded recommended diagnostic and treatment algorithms for use in practice. However, significant knowledge gaps were identified, demonstrating the need for additional research in veterinary transfusion medicine.

17 December 2018 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
IGIsabelle Goy-Thollot
Isabelle Goy-Thollot
ANAlexandra Nectoux
Alexandra Nectoux
MGMaryline Guidetti
Maryline Guidetti
BCBenjamin Chaprier
Benjamin Chaprier
SBSarah Bourgeois
Sarah Bourgeois
Urs GigerUrs Giger
Urs Giger
Background Blood typing for the A and B antigens is essential and crossmatching testing is generally recommended before transfusing blood to cats. Objective To evaluate 2 crossmatch (XM) tests. Animals Forty‐nine healthy domestic shorthair cats that had not received a blood transfusion. Methods Prospective study. Blood samples were typed for AB using immunochromatographic and flow cytometric techniques. A gel column (GC) and a feline antiglobulin‐enhanced gel column (AGC) XM tests were used for crossmatching. Results The population included 34 type A, 13 B, and 2 AB cats, with concordant results (r = 1, P < .005) by flow cytometry and immunochromatographic strip kit. The plasma from type A cats had either no or weak anti‐B alloantibodies. The plasma of 12 of 13 type B cats contained strong anti‐A alloantibodies. For crossmatching, plasma to RBC pairings were prepared using the GC (n = 446) and AGC (n = 630) tests. Both methods showed compatibilities in 329 and incompatibilities in 102 pairings including all A‐B mismatches. Additionally 15 pairings showed agglutination by the AGC but not GC method. Fourteen incompatibilities outside the expected A‐B mismatches were only revealed by AGC. Conclusions and Clinical Importance AB typing using immunochromatographic strip is as accurate as laboratory flow cytometry. The 2 XM methods had good agreement with additional incompatibilities being recognized by the AGC XM beyond A‐B incompatibilities. In clinic, feline AB typing and sensitive XM test kits are available and recommended before each transfusion, although the clinical implications of incompatible XM test results and clinical benefits of such crossmatching have not been documented.

30 July 2019 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
MGMaryline Guidetti
Maryline Guidetti
IGIsabelle Goy-Thollot
Isabelle Goy-Thollot
CBCatherine Boisvineau
Catherine Boisvineau
Urs GigerUrs Giger
Urs Giger
Background: Acute hemolytic transfusion reactions because of dog erythrocyte antigen (DEA) 1 sensitization after mismatched transfusions are serious complications. Dog erythrocyte antigen 1 expression varies from negative to weakly to strongly positive. Objectives: To assess alloimmunization after transfusion of weakly DEA 1+ blood to a DEA 1− dog. Animals: One DEA 1− recipient and 1 weakly DEA 1+ donor, and 106 control dogs. Methods: Long-term follow-up study. Matched for DEA 3, 4, 5, and 7, Dal, and Kai 1 and 2, weakly DEA 1+ donor packed red blood cells (RBCs) were transfused 3 times (0.45 mL/kg at Day 0, 16, and 37) to a DEA 1− recipient. Alloantibodies against RBCs from donor and 106 controls were determined in recipient's plasma samples using a commercial antiglobulin-enhanced immunochromatographic strip and gel tube crossmatches. Alloantibody titers were determined. Results: The DEA 1− recipient was sensitized after 16 days to ≥1657 days after transfusion to weakly DEA 1+ and otherwise matched RBCs. Strong to moderate crossmatch incompatibilities were observed between recipient's plasma and all 61 DEA 1+ crossmatched controls. Moderate to weak incompatibilities were also observed to DEA 1− controls. Anti-DEA 1 and other alloantibodies were detected over the 4.5 year observation period. Conclusions and Clinical Importance: Blood from a weakly DEA 1+ donor induces a strong and durable alloimmunization in a DEA 1− recipient dog. Additional alloantibodies developed against yet to be defined RBC antigens. Those results support the recommendation of typing dogs against DEA 1, considering weakly DEA 1+ as immunogenic, and crossmatching all previously transfused dogs.